Skip to main content
Top
Published in: Annals of Intensive Care 1/2019

Open Access 01-12-2019 | Post-Traumatic Stress Disorder | Research

Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients

Authors: Aude Sylvestre, Mélanie Adda, François Maltese, Ariane Lannelongue, Florence Daviet, Gabriel Parzy, Benjamin Coiffard, Antoine Roch, Anderson Loundou, Karine Baumstarck, Laurent Papazian

Published in: Annals of Intensive Care | Issue 1/2019

Login to get access

Abstract

Background

Venovenous extracorporeal membrane oxygenation (VV-ECMO) is associated with a significant morbidity. There is the need to investigate long-term cognitive outcome among ARDS survivors treated with VV-ECMO. We aimed to compare the prevalence of long-term cognitive dysfunction and neuropsychological impairment using a highly specific test in severe ARDS survivors treated or not treated with VV-ECMO.

Methods

Severe ARDS survivors treated between 2011 and 2017 in an ECMO Regional Referral Center were prospectively evaluated 2 years after their ICU discharge. Patients underwent an in-person interview and examination. The primary outcome was cognitive function, assessed by the Wechsler Adult Intelligence Scale 4th edition (WAIS-IV). Secondary outcomes included anxiety, depression, post-traumatic stress disorder (PTSD) and quality-of-life.

Results

We investigated 40 consecutive patients surviving from severe ARDS treated (N = 22) or not (N = 18) with VV-ECMO at a median [interquartile range] of 20 [17–22] and 22 [18–23] months after ICU discharge, respectively. Regarding the main outcome, cognitive function was below normal ranges in 12 (55%) ECMO patients and 10 (56%) non-ECMO patients (p = 0.95). Eight (36%) ECMO patients had moderate-to-severe depressive symptoms as compared with 7 (39%) non-ECMO patients (p = 0.87). Twelve (55%) ECMO patients and eight (44%) non-ECMO patients had moderate-to-severe anxiety symptoms (p = 0.53). Seven (33%) ECMO patients and eight (44%) non-ECMO patients presented a PTSD (p = 0.48). Health-related quality of life did not differ between the two groups.

Conclusions

Using the WAIS-IV, VV-ECMO treatment does not appear to worsen long-term cognitive and neuropsychological outcomes in severe ARDS patients.
Appendix
Available only for authorised users
Literature
5.
12.
go back to reference Herridge MS, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–304.CrossRef Herridge MS, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–304.CrossRef
23.
go back to reference Wechsler D. Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV): administration and scoring manual. 4th ed. San Antonio: Psychological Corporation; 2008. Wechsler D. Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV): administration and scoring manual. 4th ed. San Antonio: Psychological Corporation; 2008.
24.
go back to reference Wechsler D. Manuel d’interprétation et de cotation de la WAIS-IV. Paris: Éditions du Centre de Psychologie Appliquée; 2011. Wechsler D. Manuel d’interprétation et de cotation de la WAIS-IV. Paris: Éditions du Centre de Psychologie Appliquée; 2011.
26.
go back to reference Collet L, Cottraux J. Inventaire abrégé de la dépression de Beck (13 items). L’encéphale. 1986;10:77–9. Collet L, Cottraux J. Inventaire abrégé de la dépression de Beck (13 items). L’encéphale. 1986;10:77–9.
27.
go back to reference Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.CrossRef Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.CrossRef
28.
go back to reference Freeston MH, Ladouceur R, Thibodeau N, Gagnon F, et al. The Beck Anxiety Inventory: psychometric properties of a French translation. L’Encéphale. 1994;20(1):47–55.PubMed Freeston MH, Ladouceur R, Thibodeau N, Gagnon F, et al. The Beck Anxiety Inventory: psychometric properties of a French translation. L’Encéphale. 1994;20(1):47–55.PubMed
30.
go back to reference Hansenne M, Charles G, Pholien P, et al. Mesure subjective de l’impact d’un événement: traduction française et validation de l’échelle d’Horowitz. Psychol Med. 1993;25:86–8. Hansenne M, Charles G, Pholien P, et al. Mesure subjective de l’impact d’un événement: traduction française et validation de l’échelle d’Horowitz. Psychol Med. 1993;25:86–8.
32.
go back to reference Ware JE Jr, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide. Lincoln, RI: Quality Metric; 2005. Ware JE Jr, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide. Lincoln, RI: Quality Metric; 2005.
33.
go back to reference Leplège A, Ecosse E, Pouchot J, Coste J, Perneger TV. Le questionnaire MOS SF-36. Manuel de l’utilisateur et guide d’interprétation des scores. Paris: ESTEM; 2001. Leplège A, Ecosse E, Pouchot J, Coste J, Perneger TV. Le questionnaire MOS SF-36. Manuel de l’utilisateur et guide d’interprétation des scores. Paris: ESTEM; 2001.
Metadata
Title
Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients
Authors
Aude Sylvestre
Mélanie Adda
François Maltese
Ariane Lannelongue
Florence Daviet
Gabriel Parzy
Benjamin Coiffard
Antoine Roch
Anderson Loundou
Karine Baumstarck
Laurent Papazian
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Annals of Intensive Care / Issue 1/2019
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-019-0556-1

Other articles of this Issue 1/2019

Annals of Intensive Care 1/2019 Go to the issue